Home » Topics » Regulatory

Regulatory
RSS

FDA approves Surfaxin

March 7, 2012

First four-strain flu vaccine approved in U.S.

March 2, 2012

Esmya approved in Europe

Feb. 27, 2012

European Commission approves Glivec label update

Feb. 27, 2012

FDA grants first approval for drug-eluting coronary stent use in AMI

Feb. 23, 2012

BMS gains additional indication approvals for two anticancer drugs

Feb. 23, 2012

Line extension for Zyprexa approved in Japan

Feb. 23, 2012

Nippon Kayaku anticancer drugs approved for additional indications in Japan

Feb. 22, 2012

FDA approves first medical therapy for endogenous Cushing's syndrome

Feb. 20, 2012

Health Canada approves line extension for Prevnar 13

Feb. 17, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...